ECS Botanics to Supply Capsules for Trial Studying Potential of Medicinal Cannabis in Patients with Obstructive Sleep Apnea

MT Newswires Live

2025/07/07

ECS Botanics Holdings (ASX:ECS) is set to supply its Avani THC10 soft gel capsules to support an upcoming investigator-led clinical trial by the Center for Sleep Science at the University of Western Australia, to assess the therapeutic potential of medicinal cannabis in patients with clinically-significant obstructive sleep apnea, according to a Monday Australian bourse filing.

It will examine the impact of 10 milligrams of tetrahydrocannabinol on obstructive sleep apnea severity and contributing physiological mechanisms, along with psychomotor and cognitive outcomes.

The trial targets the enrollment of 24 participants and is expected to open within the year. Recruitment is expected to begin in July.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2549430799"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2549430799\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2549430799?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-07 14:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2549430799","market":"fut","top_or_hot":-1,"title":"ECS Botanics to Supply Capsules for Trial Studying Potential of Medicinal Cannabis in Patients with Obstructive Sleep Apnea","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/ECSDD.AU\">ECS Botanics Holdings</a> (ASX:ECS) is set to supply its Avani THC10 soft gel capsules to support an upcoming investigator-led clinical trial by the Center for Sleep Science at the University of <a href=\"https://laohu8.com/S/WER.AU\">Western Australia</a>, to assess the therapeutic potential of medicinal cannabis in patients with clinically-significant obstructive sleep apnea, according to a Monday Australian bourse filing.</p><p>It will examine the impact of 10 milligrams of tetrahydrocannabinol on obstructive sleep apnea severity and contributing physiological mechanisms, along with psychomotor and cognitive outcomes.</p><p>The trial targets the enrollment of 24 participants and is expected to open within the year. Recruitment is expected to begin in July.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ECS Botanics to Supply Capsules for Trial Studying Potential of Medicinal Cannabis in Patients with Obstructive Sleep Apnea</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nECS Botanics to Supply Capsules for Trial Studying Potential of Medicinal Cannabis in Patients with Obstructive Sleep Apnea\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-07-07 14:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/ECSDD.AU\">ECS Botanics Holdings</a> (ASX:ECS) is set to supply its Avani THC10 soft gel capsules to support an upcoming investigator-led clinical trial by the Center for Sleep Science at the University of <a href=\"https://laohu8.com/S/WER.AU\">Western Australia</a>, to assess the therapeutic potential of medicinal cannabis in patients with clinically-significant obstructive sleep apnea, according to a Monday Australian bourse filing.</p><p>It will examine the impact of 10 milligrams of tetrahydrocannabinol on obstructive sleep apnea severity and contributing physiological mechanisms, along with psychomotor and cognitive outcomes.</p><p>The trial targets the enrollment of 24 participants and is expected to open within the year. Recruitment is expected to begin in July.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ECS.AU","symbol_name":"ECS Botanics Holdings","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2549430799","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2549430799","pubTimestamp":1751868937,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ECS Botanics Holdings (ASX:ECS) is set to supply its Avani THC10 soft gel capsules to support an upcoming investigator-led clinical trial by the Center for Sleep Science at the University of Western A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ECS.AU":"ECS Botanics Holdings","XAO.AU":"标普/澳交所 普通股指数","XJO.AU":"标普/澳交所 200指数","BK7502":"大麻概念","XKO.AU":"标普/澳交所 300指数","BK7096":"制药"},"translate_title":"ECS Botanics将提供胶囊用于试验研究药用大麻在阻塞性睡眠呼吸暂停患者中的潜力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XKO.AU":0.83,"XJO.AU":0.83,"ECS.AU":0.9,"XAO.AU":0.83},"content_text":"ECS Botanics Holdings (ASX:ECS) is set to supply its Avani THC10 soft gel capsules to support an upcoming investigator-led clinical trial by the Center for Sleep Science at the University of Western Australia, to assess the therapeutic potential of medicinal cannabis in patients with clinically-significant obstructive sleep apnea, according to a Monday Australian bourse filing.It will examine the impact of 10 milligrams of tetrahydrocannabinol on obstructive sleep apnea severity and contributing physiological mechanisms, along with psychomotor and cognitive outcomes.The trial targets the enrollment of 24 participants and is expected to open within the year. Recruitment is expected to begin in July.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}